Stocks and Investing Stocks and Investing
Sun, January 19, 2025
Sat, January 18, 2025

Why Is Cliff Asness Bullish On Eli Lilly and Company (LLY)?


Published on 2025-01-19 09:21:15 - MSN
  Print publication without navigation

  • We recently compiled a list of the 10 Best Stocks to Invest in According to Billionaire Cliff Asness. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks recommended by Cliff Asness.

Cliff Asness, co-founder of AQR Capital Management, has expressed a bullish outlook on Eli Lilly and Company (LLY) due to several compelling factors. Eli Lilly has shown robust growth, particularly with its diabetes drug Mounjaro, which has also demonstrated potential in weight loss, thereby expanding its market. The company's pipeline includes promising treatments like donanemab for Alzheimer's, which could significantly boost its future revenue if approved. Additionally, Eli Lilly's stock has performed well, with a year-to-date increase of 60% as of the article's date, outperforming the S&P 500. Asness's optimism is also supported by the company's strong financial health, with a forward P/E ratio suggesting that the stock might still be undervalued given its growth prospects. This combination of current success, future potential, and financial stability underpins Asness's positive stance on Eli Lilly.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/top-stocks/why-is-cliff-asness-bullish-on-eli-lilly-and-company-lly/ar-AA1xqxzx ]
Contributing Sources